AN ASSESSMENT OF QUALITY OF LIFE IN UTHIRAVATHA SURONITHAM(RHEUMATOID ARTHRITIS)PATIENTS REPORTING AT AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA A CROSS SECTIONAL STUDY
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- National Institute of Siddha
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham
Study Overview
Brief Summary
Rheumatoid arthritis is the most commonpersistent inflammatory arthritis. The symptoms are pain, joint swelling andstiffness affecting the small joints of the hand, feet, and wrists. Large jointinvolvement, systemic symptoms and extra articular features may also occur. OBJECTIVE: To estimate the quality of life (QOL) inUthiravatha suronitham patients reporting at OPD of Ayothidoss Panditharhospital, NIS through Rheumatoid Arthritis Flare Questionnaire (RA-FQ) and toassess the predisposing factors of Uthiravatha suronitham with respect age,gender, chronicity of illness, personal history, occupational history, familyhistory, stress etc. MATERIALS ANDMETHODS: This is a Hospital based crosssectional study, included 100 Uthiravatha suronitham patients reported OPDof ayothidoss pandithar hospital were enrolled based on inclusion and exclusion criteria. After obtaininginformed consent form, data were collected by using Rheumatoid Arthritis Flare Questionnaire(RA-FQ) and Beck’s Depression Inventory form to estimate the quality of life. RESULTS : In 100 Uthiravatha suronithampatients, over all score is 42.9 in RA-FQ (Maximum 50) questionnaire. In beck’sdepression Inventory showed that 38%patients had Moderate depression and 33% patients had Severe depression. CONCLUSION: Rheumatoid arthritissignificantly affects the quality of life of patients both physically andmentally.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 30.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Age 30 TO 65 Years Male Female and Transgender K/C/O Uthiravatha suronitham(Rheumatoid Arthritis)patients with sero negative sero positive RA Lab investigations patients who are willing to give informed consent.
Exclusion Criteria
- •Age below 30 and above 65 years Patients with normal CRP Anti CCP test results Patient who are not willing to give consent form Patients defects (Osteoarthritis Psoriatic arthritis Gout arthritis).
Outcomes
Primary Outcomes
The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham
Time Frame: 6months
Secondary Outcomes
No secondary outcomes reported